No Data
No Data
Piper Sandler Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $180
Piper Sandler analyst Yasmeen Rahimi maintains $Korro Bio(KRRO.US)$ with a buy rating, and maintains the target price at $180.According to TipRanks data, the analyst has a success rate of 36.4% and
Korro Joins the Russell 2000, Russell 3000, and Russell Microcap Indexes
BMO Capital Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $120
BMO Capital analyst Kostas Biliouris maintains $Korro Bio(KRRO.US)$ with a buy rating, and maintains the target price at $120.According to TipRanks data, the analyst has a success rate of 31.0% and a
Korro to Participate in Upcoming June Investor and Scientific Conferences
Buy Rating Affirmed for Korro Bio Amid Promising KRRO-110 Preclinical Data and Superior Therapeutic Profile
HC Wainwright & Co. : The Korro Bio (KRRO.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $100.00.
HC Wainwright & Co. : The Korro Bio (KRRO.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $100.00.
No Data